Metraipolis › archive › dc_bb0a3a6bd883

Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy — Europe PMC PMID:42121946

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42121946
DOI
10.3390/cells15090845
License (as archived)
solo-consultazione
Archived
2026-11-02T18:40:38.030Z
SHA-256 of the archived text
d51ebca0927ab2edba4a49985841dcf9dd2e3e51ab7bd362ceb94a0b4bd8afcf
Stable URL of this page
https://metraipolis.com/documento/dc_bb0a3a6bd883

How to cite

Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy — Europe PMC PMID:42121946 — Europe PMC (en), https://europepmc.org/article/MED/42121946 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb0a3a6bd883 (Metraipolis archive dc_bb0a3a6bd883, sha256 d51ebca0927ab2edba4a49985841dcf9dd2e3e51ab7bd362ceb94a0b4bd8afcf)
BibTeX
@misc{dcbb0a3a6bd883,
  title = {Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy — Europe PMC PMID:42121946},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42121946},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb0a3a6bd883; sha256 d51ebca0927ab2edba4a49985841dcf9dd2e3e51ab7bd362ceb94a0b4bd8afcf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42121946. Agents can read the archived copy with the MCP tool read_document.